Should Respond Change Falls Prevention in Parkinson'S Disease?

Abstract

Get full access to this article

View all access options for this article.

References

Henderson

, Lord

, Brodie

. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15: 249–58. http://dx.doi.org/10.1016/S1474-4422(15)00389-0

Emre

, Aarsland

, Albanese

. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351: 2509–18.

Joint Formulary Committee. British National Formulary. 71st ed. London: BMJ Group and Pharmaceutical Press; 2016.

Canning

, Sherrington

, Lord

. Exercise for falls prevention in Parkinson disease: A randomized controlled trial. Neurology 2015; 84: 304–12. http://dx.doi.org/10.1212/WNL.0000000000001155

, Harmer

, Fitzgerald

. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med 2012; 366: 511–9. http://dx.doi.org/10.1056/NEJMoa1107911

Schaafsma

, Giladi

, Balash

. Gait dynamics in Parkinson's disease: Relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003; 212: 47–53.

Rochester

, Yarnall

, Baker

. Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. Brain 2012; 135: 2779–88. http://dx.doi.org/10.1093/brain/aws207

Senden

, Meijer

, Heyligers

. Importance of correcting for individual differences in the clinical diagnosis of gait disorders. Physiotherapy 2012; 98: 320–4. http://dx.doi.org/10.1016/j.physio.2011.06.002

Kim

, Brown

, Ding

. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc 2011; 59: 1019–31. http://dx.doi.org/10.1111/j.1532-5415.2011.03450.x

10.

Montero-Odasso

, Muir-Hunter

, Oteng-Amoako

. Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial. J Alzheimers Dis 2015; 43: 193–9. http://dx.doi.org/10.3233/JAD-140759

11.

Pagano

, Rengo

, Pasqualetti

. Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2015; 86: 767–73. http://dx.doi.org/10.1136/jnnp-2014-308764